This year’s J.P. Morgan Healthcare Conference in San Francisco, which wrapped on Thursday, brought together healthcare leaders from across the globe to convene, discuss industry trends and give ...

The Novo Nordisk Foundation is infusing a startup incubator it created with additional capital to strengthen innovation and entrepreneurship in Denmark and Europe. The foundation announced Thursday it ...

Pharmaceutical companies need to spend money in order to make money, and the looming loss of patent exclusivity for numerous products has these companies out in force striking business deals to fill ...

Epic Systems and several healthcare providers have sued Health Gorilla and other companies, alleging they exploited ...

AbbVie is diversifying its oncology pipeline, paying $650 million for a clinical-stage drug that goes after two targets to fight cancer. It’s the latest in a series of industry transactions for assets ...

Teladoc Health, a virtual care provider, has expanded its 24/7 urgent care service to treat more conditions, the company announced on Monday during the J.P. Morgan Healthcare Conference in San ...

On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded partnerships aimed at embedding AI even deeper into drug discovery and ...

AI rivals Anthropic and OpenAI are both expanding their large language models into healthcare. Anthropic is blending its enterprise and consumer tools in a single platform, while OpenAI is separating ...

Operating room capacity is a financial backbone for hospitals, but inefficiencies in this department often ripple outward — hurting operating margins, burning out clinicians and reducing patient ...

For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology has technology that could broaden the reach of this type ...

The race to develop new obesity drugs is playing out with measures of how much and how quickly patients shed weight. Raj Kannan, CEO of startup Alveus Therapeutics, sees the field shaping up as a ...